Policies, Guidelines and Consensus Statements: Pharmacologic Management of Type 2 Diabetese-2015 Interim Update

被引：27

作者：

Harper, William

Clement, Maureen

Goldenberg, Ronald

Hanna, Amir

Main, Andrea

Retnakaran, Ravi

Sherifali, Diana

Woo, Vincent

Yale, Jean-Francois

Cheng, Alice Y. Y.

机构：

来源：

CANADIAN JOURNAL OF DIABETES | 2015年 / 39卷 / 04期

关键词：

CANAGLIFLOZIN; EFFICACY; MELLITUS; SAFETY;

D O I：

10.1016/j.jcjd.2015.05.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：250 / 252

页数：3

共 13 条

[1]

Barnett AH, 2014, INTERNAL MED, VS6, pS6

[2] Long-term efficacy and safety of canagliflozin over 104 weeks in patients aged 55-80 years with type 2 diabetes [J].

Bode, B. ;

Stenlof, K. ;

Harris, S. ;

Sullivan, D. ;

Fung, A. ;

Usiskin, K. ;

Meininger, G. .

DIABETES OBESITY & METABOLISM, 2015, 17 (03) :294-303

[3] Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin [J].

Bolinder, J. ;

Ljunggren, O. ;

Johansson, L. ;

Wilding, J. ;

Langkilde, A. M. ;

Sjostrom, C. D. ;

Sugg, J. ;

Parikh, S. .

DIABETES OBESITY & METABOLISM, 2014, 16 (02) :159-169

[4]

Booth G, 2013, CAN J DIABETES S1, V37

[5]

European Medicines Agency Review Notice, REV DIAB MED CALL SG

[6] Pharmacologic Management of Type 2 Diabetes [J].

Harper, William ;

Clement, Maureen ;

Goldenberg, Ronald ;

Hanna, Amir ;

Main, Andrea ;

Retnakaran, Ravi ;

Sherifali, Diana ;

Woo, Vincent ;

Yale, Jean-Francois .

CANADIAN JOURNAL OF DIABETES, 2013, 37 :S61-S68

[7] A Review on the Relationship between SGLT2 Inhibitors and Cancer [J].

Lin, Hao-Wen ;

Tseng, Chin-Hsiao .

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014

[8] BAYESIAN NETWORK META-ANALYSIS TO ASSESS RELATIVE EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED WITH METFORMIN [J].

Pacou, M. ;

Taieb, V ;

Abrams, K. R. ;

Diels, J. ;

van Sanden, S. ;

Garg, M. ;

Schroeder, M. ;

Kaur, V ;

Nielsen, A. T. N. ;

Nuhoho, S. ;

Neslusan, C. ;

Hemels, M. .

VALUE IN HEALTH, 2013, 16 (07) :A609-A609

[9] Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition [J].

Peters, Anne L. ;

Buschur, Elizabeth O. ;

Buse, John B. ;

Cohan, Pejman ;

Diner, Jamie C. ;

Hirsch, Irl B. .

DIABETES CARE, 2015, 38 (09) :1687-1693

[10]

U.S. Food and Drug Administration Drug Safety Communication, FDA WARNS SGLT2 INHI

← 1 2 →